Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

A car accident on LI left one person dead & two more critically injured. The crash occurred Monday in Deer Park on Straight Path, south of Sagamore Lane.

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Surgical Warming Blanket Introduced Infection During Surgery, Lawsuit Alleges

Surgical products maker Arizant, a subsidiary of 3M, has been hit with a lawsuit charging that the Bair Hugger surgical warming blanket introduced a serious infection during a patient’s hip surgery.

The complaint alleges that the plaintiff suffered serious injuries when the Bair Hugger introduced dangerous pathogens from the operating room floor into the sterile surgical site during hip implant revision surgery. The bacteria caused a Methicillin-resistant Staphylococcus aureus (MRSA) infection. Continue reading

Posted in Defective Medical Devices, Defective Products |

Following Complaints over Sunscreen, Jessica Alba’s Honest Company Faces Scrutiny

After consumers have publicly complained about the ineffectiveness of its sunscreen, Jessica Alba’s Honest Company is under scrutiny. The Honest Company promises to sell “safe and eco-friendly household and baby care products” and markets an SPF 30 sunscreen with “broad spectrum, mineral-based protection.” According to some consumers, however, the product did little to protect them against burns. Some have taken to social media platforms to express their frustration. One twitter user posted a photo of his reddened scalp and tweeted “this is my very real result from Honest 30 SPF sunscreen. Only spent 1 hour outside. Burnt.” CNBC reports.

NBC Chicago interviewed Gretta Stabler, who applied the product on her 6-year-old daughter four times over a three hour period. “She got really burned on her arms, shoulders, legs, face, pretty much everywhere. I was angry,” Stabler said. Continue reading

Posted in Legal News |

FDA Cautions Against Mixing Up Brintellix with Brilinta

Some doctors and pharmacies have confused two different drugs with similar-sounding names, the U.S. Food and Drug Administration (FDA) warned. The agency said that it has Brintellix and Brilinta. Brintellix is an antidepressant sold by Takeda Pharmaceuticals and Astra Zeneca’s Brilinta is a blood thinner prescribed to patients who have had a heart attack or severe chest pain. The FDA said it received 50 reports of medication errors; there were 12 instances where doctors prescribed the wrong drug or the pharmacy dispensed the incorrect medication. The agency is not aware of any cases where the wrong drug was taken.

The FDA says there have been reports of medication errors since Brintellix’s approval in 2013. The two drugs have some similarities in appearance; the letter T is stamped on both tablets and in some cases both are yellow. Consumers should be aware of a few differences. Brintellix is a tear-shaped tablet stamped with the letters “TL” whereas Brilinta is a round, yellow tablet stamped with “T 90”. Continue reading

Posted in Legal News |

FDA Cautions Against Mixing Up Brintellix with Brilinta

Some doctors and pharmacies have confused two different drugs with similar-sounding names, the U.S. Food and Drug Administration (FDA) warned. The agency said that it has Brintellix and Brilinta. Brintellix is an antidepressant sold by Takeda Pharmaceuticals and Astra Zeneca’s Brilinta is a blood thinner prescribed to patients who have had a heart attack or severe chest pain. The FDA said it received 50 reports of medication errors; there were 12 instances where doctors prescribed the wrong drug or the pharmacy dispensed the incorrect medication. The agency is not aware of any cases where the wrong drug was taken.

The FDA says there have been reports of medication errors since Brintellix’s approval in 2013. The two drugs have some similarities in appearance; the letter T is stamped on both tablets and in some cases both are yellow. Consumers should be aware of a few differences. Brintellix is a tear-shaped tablet stamped with the letters “TL” whereas Brilinta is a round, yellow tablet stamped with “T 90”. Continue reading

Posted in Legal News |

New Lawsuit Filed Against Janssen Pharmaceuticals Over Levaquin Nerve Damage

Lawsuit Filed Against (Levaquin) Janssen Pharmaceuticals

Lawsuit Filed Against (Levaquin) Janssen Pharmaceuticals


Janssen Pharmaceuticals and drug distributor McKeeson Corp. were hit with a lawsuit last week in Pennsylvania federal court by a Texas woman who says the companies failed to warn of known dangers of the antibiotic Levaquin, which she alleges caused her permanent nerve damage.

The woman was administered Levaquin both during and after heart surgery in 2006, and in her complaint she contends that the drug maker did not warn either physicians or patients that using the drug could result in permanent nerve damage. The suit said that from 2004 until 2013, the drug carried a confusing label that advised consumers the side effect was rare and symptoms would disappear when the drug was discontinued, Law360 reports. Continue reading

Posted in Cipro, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , , |

Levaquin Linked to Mitochondrial Toxicity in FDA Report

Levaquin Linked to Mitochondrial Toxicity in FDA Report

Levaquin Linked to Mitochondrial Toxicity in FDA Report


The antibiotic Levofloxacin, sold under the brand names Levaquin and Cipro, is in the flouroquinolone family and widely used to treat serious infections such as pneumonia and kidney infections. Recent reports, however, suggest that the drug is linked to a condition known as mitochondrial toxicity. ABC5 in Cleveland, Ohio that a 2013 report by the U.S. Food and Drug Administration (FDA) identified this risk but, has not publicly disclosed it. A review of the FDA’s adverse event database showed that Levofloxacin has been linked to 3,000 deaths and 200,000 complaints, ABC5 reports.

In 2008, the FDA placed a black box warning on the drug in 2008 warning of nerve damage and ruptured tendons. Continue reading

Posted in Legal News, Toxic Substances | Tagged , , , , , |

Outbreak of Legionnaires’ Disease Sickens 46 in the Bronx, Kills 4

Outbreak of Legionnaires’ Disease Sickens 46 in the Bronx

Outbreak of Legionnaires’ Disease Sickens 46 in the Bronx


Since July 10th, 46 people have acquired Legionnaires’ disease in the Bronx and four people have died. According WABC, positive samples of the bacteria have been found in air conditioning at a hospital and a complex with a movie theater. Authorities are currently unsure as to whether the contaminated equipment is linked to the outbreak.

According to Mayo Clinic, Legionnaires’ disease is caused by exposure to legionella bacteria and mostly affects the lungs. Initial symptoms include headache, muscle pain chills and fever that may be 104 F or higher; these symptoms may occur two to 10 days after being exposed. Coughing (may bring up mucus and blood), shortness of breath, chest pain, gastrointestinal symptoms (nausea, vomiting, diarrhea) and confusion may occur by the second or third day. Continue reading

Posted in Legal News, Toxic Substances | Tagged , , , , , |

FDA Failed to Warn Public of Serious Side Effect Linked to Antibiotic Levaquin

FDA Failed to Warn Public of Levaquin Side Effect

FDA Failed to Warn Public of Levaquin Side Effect


The Food and Drug Administration (FDA) failed to disclose a serious side effect associated with the family of antibiotics known as fluoroquinolones identified in a 2013 agency report.

In an investigation, Cleveland television station ABC5 obtained a 2013 FDA report that raises concerns about possible “mitochondrial toxicity” associated with fluoroquinolones, which are marketed under brand names including Levaquin and Cipro and the generic form levofloxacin. These powerful antibiotics have been used to treat anthrax cases and are used for pneumonia and kidney infections. Continue reading

Posted in Cipro, Defective Products, Health Concerns, Levaquin, Pharmaceuticals | Tagged , , , , |

European Regulators Review Medtronic’s InductOs in Light of Contamination Issues

European Regulators Review Medtronic’s InductOs

European Regulators Review Medtronic’s InductOs


The European Medicines Agency (EMA) will be reviewing Medtronic’s InductOs following reports of contamination problems at a site that manufacturers one of the product’s components. InductOs is an implantable bone development product used in patients undergoing spinal fusion in the lower back and in surgeries to repair broken tibia. The kit InductOs is sold as contains its active ingredient dibotermin alfa and an absorbable collagen sponge (ACS) manufactured by Integra LifeSciences.

Regulatory Affairs Professionals Society (RAPS) reports that the contamination problems were from a site in the United States that manufactures the ACS in InductOs. In January 2014, inspectors identified “a number of major deficiencies” and Integra was issued a corrective action plan. Because of the contamination issues, the company was not allowed to import the sponge to the EU until inspectors could return and “assess the progress in eliminating the major deficiencies”. Continue reading

Posted in Legal News, Medtonic Infuse | Tagged , , , |

UPPAbaby Strollers and RumbleSeats Recalled for Choking Hazard

UPPAbaby Strollers and RumbleSeats Recalled

UPPAbaby Strollers and RumbleSeats Recalled


On July 23, the Consumer Product Safety Commission (CPSC) announced the recall of about 79,000 UPPAbaby strollers in the U.S. and Canada because the foam covering of the bumper bar could pose a choking hazard.

The recall includes the UPPAbaby 2015 CRUZ and 2015 VISTA strollers and 2015 RumbleSeats. The child can bite off and choke on the foam covering of the bumper bar. Continue reading

Posted in Defective Products, Product Recalls | Tagged , , , |

© 2005-2015 Parker Waichman LLP ®. All Rights Reserved.